CNR Institutional Research Information System

IANNOTTI, FABIO ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.588
NA - Nord America 765
EU - Europa 409
SA - Sud America 281
AF - Africa 33
OC - Oceania 3
AN - Antartide 1
Totale 3.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 730
SG - Singapore 654
CN - Cina 418
BR - Brasile 219
HK - Hong Kong 175
IT - Italia 144
VN - Vietnam 115
FR - Francia 85
KR - Corea 82
NL - Olanda 54
FI - Finlandia 38
AR - Argentina 32
IN - India 32
JP - Giappone 32
DE - Germania 22
GB - Regno Unito 20
BD - Bangladesh 19
CA - Canada 13
IL - Israele 12
MX - Messico 12
PK - Pakistan 11
ZA - Sudafrica 11
ES - Italia 8
MA - Marocco 7
UA - Ucraina 7
VE - Venezuela 7
ID - Indonesia 6
IQ - Iraq 6
PY - Paraguay 6
SA - Arabia Saudita 6
EC - Ecuador 5
KE - Kenya 4
PL - Polonia 4
RU - Federazione Russa 4
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
IE - Irlanda 3
PE - Perù 3
SE - Svezia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
BY - Bielorussia 2
GA - Gabon 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
AL - Albania 1
AQ - Antartide 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TR - Turchia 1
Totale 3.080
Salva come PNG Salva come JPEG
Città #
Singapore 365
Hefei 181
Hong Kong 171
San Jose 156
Santa Clara 141
Beijing 98
Seoul 79
Lauterbourg 69
Ashburn 62
Naples 50
Ho Chi Minh City 42
Los Angeles 35
Hanoi 34
Dallas 33
Council Bluffs 21
Helsinki 19
São Paulo 19
Tokyo 19
Lappeenranta 14
New York 14
Rio de Janeiro 14
Shenzhen 11
Buffalo 10
Minamishinagawa 10
Rome 9
Afragola 8
Casandrino 8
Frankfurt am Main 8
Orem 8
Bengaluru 7
Buenos Aires 7
Da Nang 7
Phoenix 7
Brooklyn 6
Houston 6
Johannesburg 6
Milan 6
Munich 6
Poplar 6
Amsterdam 5
Brasília 5
Chennai 5
Guangzhou 5
London 5
Mexico City 5
San Francisco 5
Asunción 4
Campinas 4
Falkenstein 4
Haiphong 4
Lahore 4
Marseille 4
Miami 4
Montreal 4
Nairobi 4
Nanjing 4
Newark 4
Turku 4
Antwerp 3
Belo Horizonte 3
Biên Hòa 3
Campo Grande 3
Caxias do Sul 3
Dhaka 3
Dublin 3
Goiânia 3
Itajubá 3
Macaé 3
Mumbai 3
New Orleans 3
Porto Alegre 3
Providence 3
Québec 3
Rabat 3
Salvador 3
Stockholm 3
São Bernardo do Campo 3
São Gonçalo 3
Tashkent 3
Viamão 3
Warsaw 3
Algiers 2
Atlanta 2
Auckland 2
Avellaneda 2
Baghdad 2
Baku 2
Barra Bonita 2
Basra 2
Berazategui 2
Boston 2
Bắc Ninh 2
Cairo 2
Caracas 2
Catania 2
Charlotte 2
Chicago 2
City of London 2
Corpus Christi 2
Cuiabá 2
Totale 1.962
Salva come PNG Salva come JPEG
Nome #
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors 102
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury 97
N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 83
Editorial: "Small molecules targeting transmembrane receptors and ion channels in drug discovery" 80
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity 80
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice 79
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. 72
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity 70
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. 68
Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis 65
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 65
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI 64
The (Poly)pharmacology of cannabidiol in neurological and neuropsychiatric disorders: Molecular mechanisms and targets 64
The gut microbiome, endocannabinoids and metabolic disorders. 60
In silico identification and experimental validation of (-)-muqubilin A, a marine norterpene peroxide, as PPARalpha/gamma-RXRalpha agonist and RARalpha positive allosteric modulator 59
Identification and characterization of cannabidiol as an ox1r antagonist by computational and in vitro functional validation 58
Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE, BuChE, and BACE‐1 Inhibitors Against Alzheimer's Disease by In Silico, In Vitro, and In Vivo Studies 56
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin 55
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling 52
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy 52
Beneficial effects of akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-palmitoyl-glycerol levels as new pparα agonists 52
N-palmitoyl-d-glucosamine, a natural monosaccharide-based glycolipid, inhibits tlr4 and prevents lps-induced inflammation and neuropathic pain in mice 51
NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 50
Alternanza Scuola Lavoro Liceo Scientifico Galilei-Mondragone (Ce), AS 2017/18 50
Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury 49
Neuroendocrine Transdifferentiation in Human Prostate Cancer Cells: An Integrated Approach 47
Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders 47
Alternanza Scuola Lavoro Liceo Scientifico Colombo-Marigliano (Na), AS 2017/18 46
Activation of cannabinoid type 1 receptor (CB1) modulates oligodendroglial process branching complexity in rat hippocampal cultures stimulated by olfactory ensheathing glia-conditioned medium 46
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 45
PPARα/γ-Targeting Amorfrutin Phytocannabinoids from Aerial Parts of Glycyrrhiza foetida 45
Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARgamma Agonist via a Combined Computational and Functional Study 44
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 44
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 42
Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice 41
Maternal omega-3 intake differentially affects the endocannabinoid system in the progeny`s neocortex and hippocampus: Impact on synaptic markers 40
Activation of Kv7 Potassium Channels Inhibits Intracellular Ca2+ Increases Triggered By TRPV1-Mediated Pain-Inducing Stimuli in F11 Immortalized Sensory Neurons 39
The endocannabinoidome in human placenta: Possible contribution to the pathogenesis of preeclampsia 39
Phytocannabinoid treatment in a mouse model of West syndrome with spontaneous seizures 38
Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome 38
Assessment of the effects of dietary vitamin d levels on olanzapine-induced metabolic side effects: Focus on the endocannabinoidome-gut microbiome axis 37
The endocannabinoid system and ppars: Focus on their signalling crosstalk, action and transcriptional regulation 36
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions 35
Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets 34
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. 33
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors 33
Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor 33
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. 32
Peripubertal cannabidiol treatment rescued behavioral and neurochemical abnormalities in MAM model of schizophrenia. 31
Early Low-Fat Diet Enriched With Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High-Fat Diet Challenge in Mice 31
Neuroprotective effects of N-oleoylglycine in a mouse model of mild traumatic brain injury 31
Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity 30
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. 29
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 26
Study of the expression profile and pharmacological role of CB1 receptor in Duchenne Muscular Dystrophy (DMD) muscles: a new opportunity to reinforce muscle repair and locomotor activity 26
Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation 25
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats 24
Identification and characterization of phytocannabinoids as novel dual PPARalpha/gamma agonists by a computational and in vitro experimental approach 24
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 23
The endocannabinoid system controls skeletal muscle cell differentiation via CB1 receptor-dependent hydrolysis of PIP2 and ihibition of Kv7 potassium channels 22
Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats 22
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in perinatal ?9-tetrahydrocannabinol occurs in schizophrenia: analyses in patients and in animal model of the disease. 22
Pharmacological actions and potential therapeutic use of cannabinoids in Duchenne's muscular dystrophy 22
Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle 21
THE NON-PSYCHOTROPIC PLANT CANNABINOIDS, CANNABIDIOL (CBD) AND CANNABIDIVARIN (CBDV) ACTIVATE AND DESENSITIZE TRPV1 CHANNELS IN VITRO: POTENTIAL FOR THE TREATMENT OF NEURONAL HYPEREXCITABILITY 21
Nociceptor plasticity: a closer look. 21
Experimental ischemia/reperfusion model impairs endocannabinoid signaling and Na+/K+ ATPase expression and activity in kidney proximal tubule cells 21
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Delta9-tetrahydrocannabinol-exposed rats 20
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 19
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 19
The endocannabinoid system in renal cells: regulation of Na+ transport by CB1 receptors through distinct cell signalling pathways 17
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 17
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders 17
Study of the expression profile and pharmacological role of the CB1 receptor in Duchenne Muscular Dystrophy (DMD) muscles: a new opportunity to reinforce muscle repair and locomotor activity 17
Attività laboratoriale "RigenerAzioni per combattere le malattie muscolari degenerative: studio di terapie innovative per ripristinare la rigenerazione tissutale nelle distrofie muscolari" nell'ambito del Progetto "RigenerAzioni: Percorsi di rigenerazione per l'economia circolare, i beni culturali e la salute" - Festival scientifico "Futuro Remoto" XXXII - Città della Scienza, Napoli, 5-8 novembre 2018 14
THE ENDOCANNABINOID SYSTEM CONTROLS SKELETAL MUSCLE CELL DIFFERENTIATION VIA CB1 RECEPTOR-DEPENDENT HYDROLYSIS OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE (PIP2) AND INHIBITION OF KV7 POTASSIUM CHANNELS 14
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity 12
Totale 3.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.485
article - articoli 9.257
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 115
Totale 19.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024107 0 0 0 0 0 0 0 0 0 5 13 89
2024/20251.138 14 6 98 52 138 25 21 96 67 68 293 260
2025/20261.940 122 232 171 278 364 79 274 77 112 147 84 0
Totale 3.185